7900 ICP-MS Increases Efficiency - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

7900 ICP-MS Increases Efficiency


Pharmaceutical Technology
Volume 38, Issue 3, pp. 14

The 7900 ICP-MS from Agilent Technolgies is a redesign of the 7700 Series. The instruments high-matrix technology allows laboratories to measure samples containing up to 25% total dissolved solids. This is 10 times higher than the current benchmark held by the 7700 ICP-MS, according to the company. The 7900’s new interface design, expansion-stage vacuum system, and orthogonal detector system (ODS) reduce background and improve sensitivity, improving signal to noise for 10-fold lower detection limits, according to the company. The patented ODS technology delivers up to 11 orders of magnitude dynamic range, from sub-ppt to percent-level concentrations, which enables users to measure trace elements and majors in the same run. In addition, the redesigned MassHunter software features a simpler user interface along with increased method automation capabilities.

Agilent Technologies

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
25%
Oversee medical treatment of patients in the US.
13%
Provide treatment for patients globally.
10%
All of the above.
43%
No government involvement in patient treatment or drug development.
10%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Source: Pharmaceutical Technology,
Click here